dc.contributor.author |
Hartl, Dominik |
|
dc.date.accessioned |
2024-01-08T07:50:37Z |
|
dc.date.available |
2024-01-08T07:50:37Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
1359-6446 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/148893 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Oxford : Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.drudis.2023.103726 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Analysis of pharma R & D productivity - a new perspective needed |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230928000000_00034 |
|
utue.personen.roh |
Schuhmacher, Alexander |
|
utue.personen.roh |
Hinder, Markus |
|
utue.personen.roh |
Stein, Alexander von Stegmann und |
|
utue.personen.roh |
Hartl, Dominik |
|
utue.personen.roh |
Gassmann, Oliver |
|
dcterms.isPartOf.ZSTitelID |
Drug Discovery Today |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 103726 |
de_DE |
dcterms.isPartOf.ZS-Volume |
28 (10) |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |